Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 1
1(33.3%)
Early Phase 1
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00540774Not ApplicableCompleted

Optical Sensor for Photodynamic Detection of Oral Pathology

Role: collaborator

NCT06365762Phase 1Completed

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

Role: lead

NCT02271815Completed

A Clinical and Imaging Study to Evaluate a Novel Dentifrice

Role: collaborator

NCT03985371Early Phase 1Completed

A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy

Role: collaborator

All 4 trials loaded